Please assess the completion status of the following clinical trial:

Trial Title: Relation Between Blood Concentration of Colchicine and Response to Colchicine Treatment in Gout Flare

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~Patients (\> 18 years old) with gout flare defined by following items :~* Identification of sodium urate crystals in synovial fluid analysis~* Or gout flare diagnosis according to Nijmegen criteria (score \> 8/13)~  * Man (2 pts)~ * History of flare (2 pts)~ * Flare involving first metatarsophalangeal joint (2.5 pts)~ * Maximum of flare within 24h (0.5pt),~ * Redness (1 pt),~ * History of hypertension or cardiovascular diseases (1.5 pts),~ * Serum urate level \> 360 µmol/l during flare (3.5 pts)~* Duration of flare \< 48 h~* Monoarticular involvement~Exclusion Criteria:~* Hypersensitivity to colchicine, fexofenadine, benzodiazepine or the excipients of these drugs~* Contra-indication to colchicine : chronic kidney disease stage 4-5, severe hepatic impairment, treatment by macrolide antibiotics~* Used of pain-killers other than acetaminophen~* Involvement in another clinical trial with drug administration~* Illiteracy~* Pregnant woman or breastfeeding

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Pharmacokinetic study (Type: OTHER): all participants will undergo pharmacokinetic study and take colchicine (1.5 mg over 1 hour), midazolam (1 mg) and fexofenadine (120 mg)

Based on this trial design, predict the completion outcome and termination type (if applicable).